Cleerly LABS vs ZEUS System (Zio Watch)
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if you need a detailed, non-invasive assessment of coronary artery disease, specifically to quantify plaque burden, characterize plaque types, and detect stenosis using CCTA. This tool is ideal for identifying patients at risk of heart attacks and guiding personalized preventive treatment strategies based on comprehensive anatomical and pathological insights.
View Cleerly LABS →Choose ZEUS System (Zio Watch) if…
Choose the ZEUS System (Zio Watch) if you require long-term continuous cardiac monitoring to detect and characterize intermittent arrhythmias, such as Atrial Fibrillation, that may not be captured during a short-term ECG. This wearable solution is best suited for patients experiencing symptoms suggestive of arrhythmias or those at risk for AFib, providing extended data collection for accurate diagnosis and management.
View ZEUS System (Zio Watch) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | ZEUS System (Zio Watch) |
|---|---|---|
| Pricing | Varies | Contact vendor |
| Deployment | Cloud, On-premise | Cloud-based system with a wearable device |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ZEUS System (Zio Watch)Tool B (ZEUS System) offers a broader and potentially simpler user experience by combining a wearable device for patients with dedicated provider and patient mobile apps. The patient app for symptom logging and educational content enhances direct patient engagement and ease of use, while Tool A's (Cleerly LABS) on-site proxy for data transfer might introduce more IT complexity for initial setup.
Clinical Value
TieBoth tools offer significant and FDA-cleared clinical value in distinct areas of cardiology. Tool A provides comprehensive plaque assessment and disease progression tracking for coronary artery disease, while Tool B excels in long-term continuous monitoring for arrhythmia detection with high physician agreement (99%). Their value is high but specialized to different clinical problems, making a direct comparison of 'more' value difficult.
Pricing & Value
Cleerly LABSTool A (Cleerly LABS) provides transparent pricing information, including a retail price, a discounted offer, and details on potential out-of-pocket costs, allowing for a clearer assessment of its value proposition. Tool B (ZEUS System) requires contacting the vendor for pricing, which makes it impossible to evaluate its value without further inquiry.
Enterprise Readiness
Cleerly LABSBoth tools are cloud-based, HIPAA compliant, have BAAs, and are FDA-cleared, indicating strong enterprise readiness. However, Tool A (Cleerly LABS) explicitly mentions integration with PACS, RIS, and EHR via its Cleerly Proxy, which is critical for seamless integration into existing hospital and radiology workflows. Tool B's integration with core hospital systems is not explicitly detailed in the provided information.
Innovation
Cleerly LABSWhile both are innovative, Tool A (Cleerly LABS) offers a more paradigm-shifting approach by moving beyond simple stenosis detection to comprehensive quantification and characterization of coronary plaque from CCTA, and tracking disease progression. This detailed plaque analysis and personalized risk assessment has the potential to redefine the standard of care for coronary artery disease.
Support & Docs
TieNeither the provided structured facts nor general web searches offered sufficiently detailed information about specific support channels, service level agreements, or extensive public documentation libraries for either tool to definitively pick a winner. Both companies appear to offer standard resources for providers and patients.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | ZEUS System (Zio Watch) |
|---|---|---|
| Tool Name | Cleerly LABS | ZEUS System (Zio Watch) |
| Company | Cleerly | iRhythm Technologies |
| Description | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | FDA-cleared, AI-powered wearable for long-term continuous cardiac monitoring, specifically designed to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias, providing actionable insights for physicians. |
| Primary Use Case | Comprehensive coronary plaque assessment and stenosis detection from CCTA. | Long-term continuous cardiac monitoring for arrhythmia detection, especially Atrial Fibrillation (AFib). |
| Key Features | AI-powered CCTA image analysis, Comprehensive coronary plaque assessment (volume, type), Stenosis detection and quantification, Ischemia detection (with Cleerly ISCHEMIA module), 3D visualization of coronary arteries, Personalized heart disease risk assessment, Tracking disease progression over time, Integration with PACS, RIS, EHR via Cleerly Proxy | Wearable biosensor (Zio Watch) for continuous ECG and PPG data collection, AI-powered algorithm (ZEUS System) for advanced arrhythmia detection and analysis, Long-term continuous monitoring for up to 14 days, Detects and characterizes Atrial Fibrillation (AFib) burden, Cloud-based data analytics and processing, Clinically actionable reports with high physician agreement (99%), ZioSuiteu00ae portal and provider mobile app for report interpretation and patient management, MyZiou00ae patient app for digital symptom logging, educational content, and reminders |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and ZEUS System (Zio Watch).
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or ZEUS System (Zio Watch)
Backers
Who funded each tool's parent company.